  See all
 |
Articles: Neuro/Psych Pharmacol |
Prior Articles
Waist Circumference is the Best Anthropometric Predictor for Insulin Resistance in Nondiabetic Patients with Schizophrenia Treated with Clozapine but not Olanzapine
Journal of Psychiatric Practice, 07/24/09
Optimal thresholds of early response to atypical antipsychotics: Application of signal detection methods
Schizophrenia Research, 07/24/09 Rapid response to paroxetine is associated with plasma paroxetine levels at 4 but not 8 weeks of treatment, and is independent of serotonin transporter promoter polymorphism in Japanese depressed patients
Human Psychopharmacology: Clinical and Experimental, 07/24/09 Buprenorphine adoption in the National Drug Abuse Treatment Clinical Trials Network
Journal of Substance Abuse Treatment, 07/24/09 In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia
Schizophrenia Research, 07/24/09 Extended release metformin for metabolic control assistance during prolonged clozapine administration: A 14 week, double-blind, parallel group, placebo-controlled study
Schizophrenia Research, 07/23/09 A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder
Psychiatry Research, 07/23/09
Exclusive Author Commentary Buprenorphine maintenance treatment in a primary care setting: Outcomes at 1 year
Journal of Substance Abuse Treatment, 07/23/09 Controlled clinical, polysomnographic and psychometric studies on differences between sleep bruxers and controls and acute effects of clonazepam as compared with placebo
European Archives of Psychiatry and Clinical Neuroscience, 07/23/09 Preliminary evidence on the association between XBP1-116C/G polymorphism and response to prophylactic treatment with valproate in bipolar disorders
Psychiatry Research, 07/23/09 Effectiveness of second-generation antipsychotics with acute-phase schizophrenia
Schizophrenia Research, 07/22/09 Influence of antipsychotics on mortality in schizophrenia: Systematic review
Schizophrenia Research, 07/22/09
Evidence Based Medicine
Ziprasidone vs clozapine in schizophrenia patients refractory to multiple antipsychotic treatments: The MOZART study
Schizophrenia Research, 07/21/09 Efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia
Human Psychopharmacology: Clinical and Experimental, 07/21/09 Paliperidone extended-release for schizophrenia: Effects on symptoms and functioning in acutely ill patients with negative symptoms
Schizophrenia Research, 07/21/09 GABAB Receptors, Schizophrenia and Sleep Dysfunction: A Review of the Relationship and its Potential Clinical and Therapeutic Implications.
CNS Drugs, 07/21/09 The effects of energy drinks alone and with alcohol on neuropsychological functioning
Human Psychopharmacology: Clinical and Experimental, 07/21/09 Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: patient characteristics and patterns and predictors of treatment retention
Addiction, 07/21/09 Hypothermia and rhabdomyolysis following olanzapine injection in an adolescent with schizophreniform disorder
General Hospital Psychiatry, 07/21/09 Bilateral posterior vitreous detachment after electroconvulsive therapy
General Hospital Psychiatry, 07/21/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Current Psychiatry, Bipolar Disorders, American Journal of Psychiatry, Addiction
more...
|
250 Available Pages
|
|
